Table of Contents
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Middle East Molecular Diagnostics Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing Prevalence of Infectious Diseases and Various Types of Cancer in the Middle East
3.2.1.2. Increase in Awareness and Acceptance of Personalized Medicines in the Middle East
3.2.1.3. Significant External Funding for Executing Research and Development Exercises
3.2.2. Restraints
3.2.2.1. Uncertain Reimbursement Scenario
3.2.2.2. Lack of High-Complexity Testing Centres in the Middle East
3.2.3. Opportunities
3.2.3.1. Massive Scope for Adoption of Molecular Diagnostics
3.2.3.2. Rise of Next-Generation Ultrasensitive Molecular Diagnostics
3.2.3.3. Novel Revenue Streams
3.2.4. Challenges
3.2.4.1. COVID-19 Impact on Middle East Molecular Diagnostics
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Middle East Molecular Diagnostics Market Overview
4.1. Market Size & Forecast by Value, 2019-2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Product
4.2.1.1. Systems
4.2.1.2. Kits & Consumables
4.2.1.3. Software
4.2.1.4. Other Product
4.2.2. By Testing Location
4.2.2.1. Laboratory Testing
4.2.2.2. Point-of-Care Testing
4.2.3. By Technology
4.2.3.1. Polymerase Chain Reaction (PCR)
4.2.3.2. Next-Generation Sequencing
4.2.3.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
4.2.3.4. Microarray
4.2.3.5. In-Situ Hybridization (ISH)
4.2.3.6. Immunohistochemistry (IHC)
4.2.3.7. Other Technologies
4.2.4. By Application
4.2.4.1. Core Molecular Diagnostics
4.2.4.2. Reproductive Genetics
4.2.4.3. Companion Diagnostics (CDx)
4.2.4.4. Liquid Biopsy
4.2.4.5. Other Applications
4.2.5. By End User
4.2.5.1. Hospitals
4.2.5.2. Diagnostic Centres
4.2.5.3. Out-Patient Clinics/General Practitioners
4.2.5.4. Research Laboratories
4.2.5.5. Other End Users
4.2.6. By Country
4.2.6.1. Saudi Arabia
4.2.6.2. UAE
4.2.6.3. Lebanon
4.2.6.4. Bahrain
4.2.6.5. Oman
4.2.6.6. Qatar
4.2.6.7. Rest of Middle East
5. Saudi Arabia Molecular Diagnostics Market
5.1.1. Market Size & Forecast by Value, 2019-2 029
5.1.2. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.2. By Testing Location
5.2.3. By Technology
5.2.4. By Application
5.2.5. By End Users
6. UAE Molecular Diagnostics Market
6.1.1. Market Size & Forecast by Value, 2019-2 029
6.1.2. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Testing Location
6.2.3. By Technology
6.2.4. By Application
6.2.5. By End Users
7. Lebanon Molecular Diagnostics Market
7.1. Market Size & Forecast by Value, 2019-2 029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Testing Location
7.2.3. By Technology
7.2.4. By Application
7.2.5. By End Users
8. Bahrain Molecular Diagnostics Market
8.1. Market Size & Forecast by Value, 2019-2 029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Testing Location
8.2.3. By Technology
8.2.4. By Application
8.2.5. By End Users
9. Oman Molecular Diagnostics Market
9.1. Market Size & Forecast by Value, 2019-2 029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Testing Location
9.2.3. By Technology
9.2.4. By Application
9.2.5. By End Users
10. Qatar Molecular Diagnostics Market
10.1. Market Size & Forecast by Value, 2019-2 029
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Testing Location
10.2.3. By Technology
10.2.4. By Application
10.2.5. By End Users
11. Rest of Middle East Molecular Diagnostics Market
11.1. Market Size & Forecast by Value, 2019-2 029
11.1.1. By Value (USD Million)
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Testing Location
11.2.3. By Technology
11.2.4. By Application
11.2.5. By End Users
12. Competitive Landscape
12.1. List of Key Players and Their Offerings
12.2. Middle East Molecular Diagnostics Company Market Share Analysis, 2022
12.3. Competitive Benchmarking, By Operating Parameters
12.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, and others)
13. Impact of Covid-19 on Middle East Molecular Diagnostics Market
14. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
14.1. Abbott
14.2. Agilent Technologies, Inc.
14.3. bioMerieux SA
14.4. Babirus Medical Equipment LLC
14.5. Bio-Rad Laboratories, Inc.
14.6. Danaher
14.7. F. Hoffmann-La Roche Ltd.
14.8. Guardant Health
14.9. Illumina, Inc.
14.10. QIAGEN N.V.
14.11. Thermo Fisher Scientific Inc
14.12. Other prominent players.
15. Key Strategic Recommendations
16. Research Methodology
16.1. Qualitative Research
16.1.1. Primary & Secondary Research
16.2. Quantitative Research
16.3. Market Breakdown & Data Triangulation
16.3.1. Secondary Research
16.3.2. Primary Research
16.4. Breakdown of Primary Research Respondents, By Region
16.5. Assumption & Limitation
*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable